Today
-2.88%
5 Days
-2.96%
1 Month
-6.55%
6 Months
+25.33%
Year to Date
+14.62%
1 Year
+27.38%
• Morgan Stanley shares declined amid macroeconomic headwinds and sector-wide financial market pressures. • Technical indicators show a MACD sell signal and Williams %R oversold conditions. • The company reported $114.74B annual revenue with analysts maintaining Buy ratings.
• Treasury yields and market headwinds drove Morgan Stanley's downward stock pullback. • Technical indicators show a MACD sell signal and an oversold Williams %R. • Annual revenue reached $114.74 billion with net profit totaling $16.25 billion.
• Morgan Stanley's momentum grew from market stabilization and investor interest in financials. • The firm announced plans to build a new regional operations hub in Dallas. • Morgan Stanley reported annual revenue of $114.74B and net profit of $16.25B.
• Macroeconomic uncertainty and breached technical support levels drove selling pressure. • Institutional investors reallocated capital into defensive assets amid near-term caution. • Morgan Stanley shows neutral momentum indicators and an oversold Williams %R.
• Morgan Stanley reports $114.74 billion in annual revenue and $16.25 billion in profit. • Increased global merger and acquisition activity bolsters the firm’s investment banking outlook. • Analysts maintain an average price target of $236.05 for Morgan Stanley shares.
• Goldman Sachs shares rose on shifting Federal Reserve policy and market rate expectations. • Expected growth in M&A advisory and equity underwriting drives optimistic investment banking forecasts. • Institutional demand remains supported by consistent capital return programs and passive buying pressure.


| Shareholders | Proportion |
|---|---|
| Mitsubishi UFJ Financial Group Inc | 24.11% |
| State Street Investment Management (US) | 6.58% |
| Vanguard Capital Management, LLC | 4.93% |
| BlackRock Institutional Trust Company, N.A. | 3.86% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 32.88% |
| Holding Company | 24.15% |
| Investment Advisor/Hedge Fund | 21.67% |
| Research Firm | 2.47% |
Related Instruments